AI News NQ Analysis

60-year-old Woman with Multiple Chronic Diseases Still Severe After Vaccination; High-Risk COVID-19 Group Begins Second Dose

NQ Score 91/100

AI Summary (NQ-processed)

Taiwan's CDC announced that a second dose of the COVID-19 vaccine is now available for high-risk groups, including seniors over 65, indigenous people aged 55-64, and immunocompromised individuals over 6 months old. This aims to enhance protection against severe illness. With approximately 1 million vaccine doses in stock, about 750,000 seniors over 65 can receive their second dose by the end of April. Despite low current transmission, severe cases highlight the importance of booster shots for vulnerable populations.

AI analysis data is not yet available.

Frequently Asked Questions

Q: Who is eligible for the second dose of the COVID-19 vaccine?
A: Seniors aged 65 and above, indigenous people aged 55 to 64, and patients aged 6 months and above with immunodeficiency or weakened immunity are eligible.
Q: What is the interval between two doses?
A: The interval between two doses must be 180 days.